Tumor-associated macrophages and risk of recurrence in stage III colorectal cancer.

Colorectal Neoplasms / drug therapy Humans Macrophages / pathology Prognosis Progression-Free Survival Tumor-Associated Macrophages
adjuvant therapy cancer immunology colorectal cancer macrophage polarization tumor-associated macrophages

Journal

The journal of pathology. Clinical research
ISSN: 2056-4538
Titre abrégé: J Pathol Clin Res
Pays: England
ID NLM: 101658534

Informations de publication

Date de publication:
07 2022
Historique:
revised: 08 02 2022
received: 18 01 2022
accepted: 17 02 2022
pubmed: 24 3 2022
medline: 7 6 2022
entrez: 23 3 2022
Statut: ppublish

Résumé

Tumor-associated macrophages (TAMs) have a unique favorable effect on the prognosis of colorectal cancer (CRC), although their association with stage-specific outcomes remains unclear. We assessed the densities of CD68

Identifiants

DOI: 10.1002/cjp2.267 PMID: 35318822 PMC: PMC9161313
pubmed: 35318822
doi: 10.1002/cjp2.267
pmc: PMC9161313
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

307-312

Subventions

Organisme : NCI NIH HHS
ID : R35 CA197735
Pays : United States

Informations de copyright

© 2022 The Authors. The Journal of Pathology: Clinical Research published by The Pathological Society of Great Britain and Ireland & John Wiley & Sons, Ltd.

Références

Int J Colorectal Dis. 2020 Sep;35(9):1651-1661
pubmed: 32666290
Annu Rev Pathol. 2020 Jan 24;15:123-147
pubmed: 31530089
Cancer Treat Rev. 2019 May;75:1-11
pubmed: 30849607
Nat Rev Clin Oncol. 2017 Jul;14(7):399-416
pubmed: 28117416
J Clin Oncol. 2015 Dec 10;33(35):4176-87
pubmed: 26527776
N Engl J Med. 2018 Mar 29;378(13):1177-1188
pubmed: 29590544
Cancer Immunol Res. 2021 Jan;9(1):8-19
pubmed: 33023967
Immunity. 2014 Jul 17;41(1):14-20
pubmed: 25035950
Lancet Oncol. 2020 Dec;21(12):1620-1629
pubmed: 33271092
Nucleic Acids Res. 2016 May 5;44(8):e71
pubmed: 26704973
Clin Cancer Res. 2012 Dec 1;18(23):6531-41
pubmed: 23045248
Oncoimmunology. 2017 Jul 12;6(12):e1342918
pubmed: 29209561
Nat Methods. 2015 May;12(5):453-7
pubmed: 25822800
JAMA Oncol. 2019 Dec 1;5(12):1710-1717
pubmed: 31621801
Ann Oncol. 2020 Jul;31(7):921-929
pubmed: 32294529
N Engl J Med. 2004 Jun 3;350(23):2343-51
pubmed: 15175436

Auteurs

Tommaso Cavalleri (T)

Laboratory of Molecular Gastroenterology, IRCCS Humanitas Research Hospital, Milan, Italy.

Luana Greco (L)

Laboratory of Molecular Gastroenterology, IRCCS Humanitas Research Hospital, Milan, Italy.
ORCID: 0000-0002-6507-3257

Federica Rubbino (F)

Laboratory of Molecular Gastroenterology, IRCCS Humanitas Research Hospital, Milan, Italy.

Tsuyoshi Hamada (T)

Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Maria Quaranta (M)

IBD Center - Laboratory of Gastrointestinal Immunopathology, IRCCS Humanitas Research Hospital, Milan, Italy.

Fabio Grizzi (F)

Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Department of Immunology and Inflammation, IRCCS Humanitas Research Hospital, Milan, Italy.

Elisabetta Sauta (E)

Department of Electrical, Computer and Biomedical Engineering, University of Pavia, Pavia, Italy.

Vincenzo Craviotto (V)

Department of Gastroenterology, IRCCS Humanitas Research Hospital, Milan, Italy.

Paola Bossi (P)

Department of Pathology, IRCCS Humanitas Research Hospital, Milan, Italy.

Stefania Vetrano (S)

IBD Center - Laboratory of Gastrointestinal Immunopathology, IRCCS Humanitas Research Hospital, Milan, Italy.
Department of Biomedical Sciences, Humanitas University, Milan, Italy.

Lorenza Rimassa (L)

Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy.

Valter Torri (V)

Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

Riccardo Bellazzi (R)

Department of Electrical, Computer and Biomedical Engineering, University of Pavia, Pavia, Italy.

Alberto Mantovani (A)

Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Department of Immunology and Inflammation, IRCCS Humanitas Research Hospital, Milan, Italy.
The William Harvey Research Institute, Queen Mary University of London, London, UK.

Shuji Ogino (S)

Program in Molecular Pathological Epidemiology, Department of Pathology, Brigham & Women's Hospital and Harvard Medical School, Boston, MA, USA.
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Associate Member, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Cancer Immunology and Cancer Epidemiology Programs, Dana-Farber Harvard Cancer Center, Boston, MA, USA.
ORCID: 0000-0002-3909-2323

Alberto Malesci (A)

Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Department of Gastroenterology, IRCCS Humanitas Research Hospital, Milan, Italy.

Luigi Laghi (L)

Laboratory of Molecular Gastroenterology, IRCCS Humanitas Research Hospital, Milan, Italy.
Department of Medicine and Surgery, University of Parma, Parma, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Maladies de l'appareil digestif › Maladies gastro-intestinales › Maladies intestinales › Maladies du rectum › Tumeurs colorectales › Tumor-associated macrophages and risk of...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Tumor-associated macrophages and risk of...
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Phagocytes › Macrophages › Tumor-associated macrophages and risk of...
questionsmedicales.fr › Diagnostic › Pronostic › Tumor-associated macrophages and risk of...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Analyse de survie › Survie sans progression › Tumor-associated macrophages and risk of...
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Phagocytes › Macrophages › Macrophages associés aux tumeurs › Tumor-associated macrophages and risk of...